PN-1792

N/A

Report date: 2025/01/26 16:46:20

Base Information

Drug NamePN-1792
Drug Alias Nameanti-Pseudomonas aeruginosa bacteriophage (Pherecydes Pharma)anti-Pseudomonas aeruginosa bacteriophage (PHAXIAM Therapeutics)PN-1792
ClassificationBiologics > Bacteriophages
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMultidrug-Resistant InfectionRespiratory Tract InfectionsPneumonia, Bacterial +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPherecydes Pharma
China Registration ClassN/A

Develop Information

Active CompaniesPhaxiam Therapeutics SA
Inactive CompaniesPherecydes Pharma
Active IndicationsMultidrug-Resistant InfectionRespiratory Tract InfectionsPneumonia, Bacterial +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A